These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients. Tsang WK; Tong KL; Yeung S; Lee W; Chan HW Transplant Proc; 2000 Nov; 32(7):1755-6. PubMed ID: 11119921 [No Abstract] [Full Text] [Related]
7. Tolerability of mycophenolate mofetil in organ transplant recipients. Schweizer RT; Meisterling LD Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540 [No Abstract] [Full Text] [Related]
8. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report. Jurewicz WA Transplant Proc; 1999 Nov; 31(7A):64S-66S. PubMed ID: 10576048 [No Abstract] [Full Text] [Related]
9. Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study. Campistol JM; Mazuecos A; Segura J; Osuna A; Herrero JC; Andres A; Oppenheimer F; Gomez de la Camara A; Martinez MA; Morales JM Transplant Proc; 1999 Sep; 31(6):2267-9. PubMed ID: 10500571 [No Abstract] [Full Text] [Related]
10. Effect of mycophenolate mofetil in combination with standard immunosuppression on chronic transplant nephropathy: 1 year experience. Khachatryan N; Wauters JP; Vogel G Transplant Proc; 2002 May; 34(3):807-8. PubMed ID: 12034190 [No Abstract] [Full Text] [Related]
11. Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients. Suhail SM; Vathsala A; Lou HX; Woo KT Transplant Proc; 2000 Nov; 32(7):1757-8. PubMed ID: 11119922 [No Abstract] [Full Text] [Related]
12. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy. Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J Transplant Proc; 1997; 29(1-2):334-6. PubMed ID: 9123027 [No Abstract] [Full Text] [Related]
13. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation. Taheri M; Pourmand G; Mehrsai AR; Mansoori D Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105 [No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy. Park JH; Park JH; Yang CW; Kim YS; Kim SY; Moon IS; Koh YB; Bang BK Transplant Proc; 2000 Nov; 32(7):1747. PubMed ID: 11119917 [No Abstract] [Full Text] [Related]
15. A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus. Daoud AJ; Schroeder TJ; Shah M; Hariharan S; Peddi VR; Weiskittel P; First MR Transplant Proc; 1998 Dec; 30(8):4079-81. PubMed ID: 9865303 [No Abstract] [Full Text] [Related]
16. Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil. Jain S; Metcalfe M; White SA; Furness PN; Nicholson ML Transplant Proc; 2001 May; 33(3):2165-6. PubMed ID: 11377488 [No Abstract] [Full Text] [Related]
17. Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction. Islam MS; Francos GC; Dunn SR; Burke JF Transplant Proc; 1998 Aug; 30(5):2230-1. PubMed ID: 9723452 [No Abstract] [Full Text] [Related]
18. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients. Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505 [No Abstract] [Full Text] [Related]
19. Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients. Fritsche L; Sperschneider H; Budde K; Giessing M; Morgera S; Schröder K; Stein G; Neumayer HH Transplant Proc; 1998 Jun; 30(4):1190-1. PubMed ID: 9636481 [No Abstract] [Full Text] [Related]
20. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation. Wüthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310 [No Abstract] [Full Text] [Related] [Next] [New Search]